{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T19:32:57Z","timestamp":1777318377251,"version":"3.51.4"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T00:00:00Z","timestamp":1582848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000182","name":"Medical Research and Materiel Command","doi-asserted-by":"publisher","award":["W81-XWH-11-2-0-0174"],"award-info":[{"award-number":["W81-XWH-11-2-0-0174"]}],"id":[{"id":"10.13039\/100000182","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000182","name":"Medical Research and Materiel Command","doi-asserted-by":"publisher","award":["W81-XWH-18-C-0337"],"award-info":[{"award-number":["W81-XWH-18-C-0337"]}],"id":[{"id":"10.13039\/100000182","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0229424","type":"journal-article","created":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T13:27:24Z","timestamp":1582896444000},"page":"e0229424","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Performance evaluation of a laboratory developed PCR test for quantitation of HIV-2 viral RNA"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3142-8643","authenticated-orcid":true,"given":"Linda L.","family":"Jagodzinski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark M.","family":"Manak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holly R.","family":"Hack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila A.","family":"Peel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,2,28]]},"reference":[{"key":"pone.0229424.ref001","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.meegid.2016.08.010","article-title":"Hiv-2 molecular epidemiology","volume":"46","author":"B Visseaux","year":"2016","journal-title":"Infect Genet Evol"},{"issue":"10","key":"pone.0229424.ref002","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/QAD.0000000000001485","article-title":"HIV type 2 epidemic in Spain: challenges and missing opportunities","volume":"31","author":"C de Mendoza","year":"2017","journal-title":"AIDS"},{"issue":"2","key":"pone.0229424.ref003","doi-asserted-by":"crossref","first-page":"e000227","DOI":"10.1136\/bmjgh-2016-000227","article-title":"UNAIDS 90-90-90 targets to end the AIDS epidemic by 2020 are not realistic: comment on \"Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades\"","volume":"2","author":"LE Bain","year":"2017","journal-title":"BMJ Glob Health"},{"key":"pone.0229424.ref004","unstructured":"https:\/\/www.aidsdatahub.org\/sites\/default\/files\/publication\/UNAIDS_UD."},{"issue":"2","key":"pone.0229424.ref005","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1111\/trf.13600","article-title":"Two human immunodeficiency virus Type 2 cases in US blood donors including serologic, molecular, and genomic characterization of an epidemiologically unusual case","volume":"56","author":"SL Stramer","year":"2016","journal-title":"Transfusion"},{"issue":"29","key":"pone.0229424.ref006","first-page":"985","article-title":"HIV-2 Infection Surveillance\u2014United States, 1987\u20132009","volume":"60","author":"Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"pone.0229424.ref007","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/QAD.0000000000001758","article-title":"The influence of human leukocyte antigen-types on disease progression among HIV-2 infected patients in Guinea-Bissau","volume":"32","author":"D Thomsen","year":"2018","journal-title":"AIDS"},{"issue":"7","key":"pone.0229424.ref008","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.4049\/jimmunol.1600693","article-title":"Preservation of Lymphopoietic Potential and Virus Suppressive Capacity by CD8+ T Cells in HIV-2-Infected Controllers","volume":"197","author":"M Angin","year":"2016","journal-title":"J Immunol"},{"issue":"3","key":"pone.0229424.ref009","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/cei.13280","article-title":"Delayed disease progression in HIV-2: the importance of TRIM5alpha and the retroviral capsid","volume":"196","author":"MT Boswell","year":"2019","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"pone.0229424.ref010","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/infdis\/jiu165","article-title":"Protection versus pathology in aviremic and high viral load HIV-2 infection-the pivotal role of immune activation and T-cell kinetics","volume":"210","author":"A Hegedus","year":"2014","journal-title":"J Infect Dis"},{"issue":"3","key":"pone.0229424.ref011","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1113244","article-title":"Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection","volume":"367","author":"J Esbjornsson","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"pone.0229424.ref012","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/COH.0000000000000299","article-title":"Mortality and survival patterns of people living with HIV-2","volume":"11","author":"B Tchounga","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"key":"pone.0229424.ref013","doi-asserted-by":"crossref","first-page":"40","DOI":"10.11604\/pamj.2016.25.40.8329","article-title":"High prevalence and excess mortality of late presenters among HIV-1, HIV-2 and HIV-1\/2 dually infected patients in Guinea-Bissau\u2014a cohort study from West Africa","volume":"25","author":"BL Honge","year":"2016","journal-title":"Pan Afr Med J"},{"issue":"10","key":"pone.0229424.ref014","first-page":"1521","article-title":"Dolutegravir in HIV-2-Infected Patients With Resistant Virus to First-line Integrase Inhibitors From the French Named Patient Program","volume":"60","author":"D Descamps","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"7","key":"pone.0229424.ref015","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1074\/jbc.RA117.000177","article-title":"Amino acid residues in HIV-2 reverse transcriptase that restrict the development of nucleoside analogue resistance through the excision pathway","volume":"293","author":"M Alvarez","year":"2018","journal-title":"J Biol Chem"},{"issue":"6","key":"pone.0229424.ref016","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1128\/AAC.00405-13","article-title":"Complex patterns of protease inhibitor resistance among antiretroviral treatment-experienced HIV-2 patients from Senegal: implications for second-line therapy","volume":"57","author":"DN Raugi","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"pone.0229424.ref017","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/aid.2018.0282","article-title":"Partial pol Sequences from Drug Naive HIV-2 Infected Individuals from Maharashtra, India","volume":"35","author":"SS Ambike","year":"2019","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"7","key":"pone.0229424.ref018","doi-asserted-by":"crossref","first-page":"e390","DOI":"10.1016\/S2352-3018(18)30094-8","article-title":"90-90-90 for HIV-2? Ending the HIV-2 epidemic by enhancing care and clinical management of patients infected with HIV-2","volume":"5","author":"GS Gottlieb","year":"2018","journal-title":"Lancet HIV"},{"issue":"7","key":"pone.0229424.ref019","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/jac\/dkx090","article-title":"Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response","volume":"72","author":"S Requena","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"pone.0229424.ref020","doi-asserted-by":"crossref","first-page":"20044","DOI":"10.7448\/IAS.19.1.20044","article-title":"Immunologic response in treatment-naive HIV-2-infected patients: the IeDEA West Africa cohort","volume":"19","author":"E Balestre","year":"2016","journal-title":"J Int AIDS Soc"},{"issue":"8","key":"pone.0229424.ref021","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/QAD.0000000000000244","article-title":"Genotypic resistance profiles of HIV-2-treated patients in West Africa","volume":"28","author":"C Charpentier","year":"2014","journal-title":"AIDS"},{"issue":"10","key":"pone.0229424.ref022","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1093\/jac\/dkx210","article-title":"CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study","volume":"72","author":"L Wittkop","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"pone.0229424.ref023","doi-asserted-by":"crossref","first-page":"ofz063","DOI":"10.1093\/ofid\/ofz063","article-title":"Human Immunodeficiency Virus (HIV) 2 Superinfection in a Patient Receiving Antiretroviral Therapy With Longstanding HIV-1 Viral Load Suppression","volume":"6","author":"F Ceia","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"pone.0229424.ref024","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jcv.2016.11.011","article-title":"Clinical validation of a novel diagnostic HIV-2 total nucleic acid qualitative assay using the Abbott m2000 platform: Implications for complementary HIV-2 nucleic acid testing for the CDC 4th generation HIV diagnostic testing algorithm","volume":"86","author":"M Chang","year":"2017","journal-title":"J Clin Virol"},{"key":"pone.0229424.ref025","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jcv.2013.09.007","article-title":"Validation and clinical use of a sensitive HIV-2 viral load assay that uses a whole virus internal control","volume":"581","author":"LM Styer","year":"2013","journal-title":"J Clin Virol"},{"issue":"2","key":"pone.0229424.ref026","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jcv.2012.06.024","article-title":"Validation for clinical use of a novel HIV-2 plasma RNA viral load assay using the Abbott m2000 platform","volume":"55","author":"M Chang","year":"2012","journal-title":"J Clin Virol"},{"key":"pone.0229424.ref027","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jcv.2017.10.013","article-title":"Detection and differentiation of HIV-2 using the point-of-care Alere q HIV-1\/2 Detect nucleic acid test","volume":"97","author":"M Chang","year":"2017","journal-title":"J Clin Virol"},{"issue":"5","key":"pone.0229424.ref028","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7883\/yoken.JJID.2015.309","article-title":"Qualitative Real-Time PCR Assay for HIV-1 and HIV-2 RNA","volume":"69","author":"S Yamazaki","year":"2016","journal-title":"Jpn J Infect Dis"},{"issue":"9","key":"pone.0229424.ref029","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1128\/JCM.00755-17","article-title":"New Highly Sensitive Real-Time PCR Assay for HIV-2 Group A and Group B DNA Quantification","volume":"55","author":"M Bertine","year":"2017","journal-title":"J Clin Microbiol"},{"key":"pone.0229424.ref030","unstructured":"WHO. What's new in treatment monitoring: Viral load and CD4 testing. https:\/\/wwwwhoint\/hiv\/pub\/arv\/treatment-monitoring-info-2017\/en\/2017."},{"issue":"3","key":"pone.0229424.ref031","doi-asserted-by":"crossref","first-page":"19675","DOI":"10.7448\/IAS.17.4.19675","article-title":"Validation of an ultrasensitive digital droplet PCR assay for HIV-2 plasma RNA quantification","volume":"17","author":"J Ruelle","year":"2014","journal-title":"J Int AIDS Soc"},{"issue":"6","key":"pone.0229424.ref032","doi-asserted-by":"crossref","first-page":"e14313","DOI":"10.1097\/MD.0000000000014313","article-title":"Drug resistance mutations and viral load in human immunodeficiency virus type 2 and dual HIV-1\/HIV-2 infected patients in Ghana","volume":"98","author":"CZ Abana","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"pone.0229424.ref033","doi-asserted-by":"crossref","first-page":"e96554","DOI":"10.1371\/journal.pone.0096554","article-title":"Discrepant amplification results during the development of an assay leads to reclassification of two AIDS reagent repository HIV-2 isolates as HIV-1","volume":"9","author":"LL Jagodzinski","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"pone.0229424.ref034","doi-asserted-by":"crossref","first-page":"e16142","DOI":"10.1371\/journal.pone.0016142","article-title":"RNA and DNA bacteriophages as molecular diagnosis controls in clinical virology: a comprehensive study of more than 45,000 routine PCR tests","volume":"6","author":"L Ninove","year":"2011","journal-title":"PLoS One"},{"issue":"10","key":"pone.0229424.ref035","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.1128\/JVI.79.10.6089-6101.2005","article-title":"Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines","volume":"79","author":"BK Brown","year":"2005","journal-title":"J Virol"},{"issue":"8","key":"pone.0229424.ref036","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1128\/JCM.37.8.2557-2563.1999","article-title":"Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes","volume":"37","author":"NL Michael","year":"1999","journal-title":"J Clin Microbiol"},{"issue":"2","key":"pone.0229424.ref037","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jviromet.2011.05.025","article-title":"Preparation and evaluation of the 1st international standard for the quantitation of HIV-2 RNA in plasma","volume":"175","author":"H Holmes","year":"2011","journal-title":"J Virol Methods"},{"key":"pone.0229424.ref038","article-title":"Characterization of HIV-2 Subtype A and B virus controls using quantitative Real-Time PCR assay","author":"VR Huang C","year":"2011","journal-title":"Clinical Virology Symposuim"},{"issue":"4","key":"pone.0229424.ref039","first-page":"2","article-title":"Correct use of percent coefficient of variation (%CV) formula for log-transformed data","volume":"6","author":"TS Canchola JA","year":"2017","journal-title":"MOJ Proteomics & Bioinformatics"},{"issue":"3","key":"pone.0229424.ref040","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1128\/CMR.00074-09","article-title":"Validation of laboratory-developed molecular assays for infectious diseases","volume":"23","author":"EM Burd","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"pone.0229424.ref041","volume-title":"Quantitative molecular methods for infectious diseases; Approved guideline neCdM-AVW","author":"CLSI\/NCCLS","year":"2011"},{"issue":"4","key":"pone.0229424.ref042","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1086\/315010","article-title":"Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2","volume":"180","author":"SJ Popper","year":"1999","journal-title":"J Infect Dis"},{"issue":"5","key":"pone.0229424.ref043","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01922-18","article-title":"Impact of Early Antiretroviral Therapy on Detection of Cell-Associated HIV-1 Nucleic Acid in Blood by the Roche Cobas TaqMan Test","volume":"57","author":"LL Jagodzinski","year":"2019","journal-title":"J Clin Microbiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229424","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T13:27:51Z","timestamp":1582896471000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229424"}},"subtitle":[],"editor":[{"given":"Pierre","family":"Roques","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,2,28]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0229424","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,28]]}}}